Loading
Latest filing published 20 Mar 2024 for Biohit Oyj, €8,000. Read the official filing
Suvi Elomaa, listed as senior executive, appears in our data through filings on Biohit Oyj shares, published by Nasdaq Helsinki. We count 2 filings; the first trade dates from 20 March 2023 and the latest from 18 March 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 20 March 2024, reports a transaction of €8,000 in Biohit Oyj. Source: insider filings from Nasdaq Helsinki. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 1 declaration